BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 18786162)

  • 1. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
    Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
    Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
    Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
    Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease.
    Fehér A; Juhász A; Rimanóczy A; Kálmán J; Janka Z
    Alzheimer Dis Assoc Disord; 2009; 23(3):224-8. PubMed ID: 19812463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
    Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment.
    Thomann PA; Roth AS; Dos Santos V; Toro P; Essig M; Schröder J
    Dement Geriatr Cogn Disord; 2008; 26(4):300-5. PubMed ID: 18843182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli.
    van Wingen G; Rijpkema M; Franke B; van Eijndhoven P; Tendolkar I; Verkes RJ; Buitelaar J; Fernández G
    Neuroimage; 2010 Apr; 50(3):1212-8. PubMed ID: 20097294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.
    Montag C; Weber B; Fliessbach K; Elger C; Reuter M
    Psychol Med; 2009 Nov; 39(11):1831-9. PubMed ID: 19335934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.
    Voineskos AN; Lerch JP; Felsky D; Shaikh S; Rajji TK; Miranda D; Lobaugh NJ; Mulsant BH; Pollock BG; Kennedy JL
    Arch Gen Psychiatry; 2011 Feb; 68(2):198-206. PubMed ID: 21300947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.
    Tsai SJ; Gau YT; Liu ME; Hsieh CH; Liou YJ; Hong CJ
    Neurosci Lett; 2008 Mar; 433(2):158-62. PubMed ID: 18242855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Tsuneki H; Kawasaki Y; Zhou SY; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Neurosci Lett; 2008 Apr; 435(1):34-9. PubMed ID: 18325670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
    Tsai SJ; Hong CJ; Liu HC; Liu TY; Liou YJ
    Dement Geriatr Cogn Disord; 2006; 21(3):139-43. PubMed ID: 16391475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.
    Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L
    Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.